# Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

> **NCT00497081** · PHASE2 · COMPLETED · sponsor: **San Francisco Department of Public Health** · enrollment: 60 (actual)

## Conditions studied

- Substance Abuse
- HIV Infections

## Interventions

- **DRUG:** mirtazapine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00497081
- **Lead sponsor:** San Francisco Department of Public Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-01-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497081, "Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors". Retrieved via MORVS 2026-11-03 from https://api.morvs.ai/clinical/NCT00497081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*